Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2024
Provided By GlobeNewswire
Last update: Aug 13, 2024
BOSTON and LONDON, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today reported financial results and business highlights for the second quarter ended June 30, 2024.
Read more at globenewswire.com
